Simultaneous measurement of excitation-contraction coupling parameters identifies mechanisms underlying contractile responses of hiPSC-derived cardiomyocytes

Cardiomyocytes from human induced pluripotent stem cells (hiPSC-CMs) are increasingly recognized as valuable for determining the effects of drugs on ion channels but they do not always accurately predict contractile responses of the human heart. This is in part attributable to their immaturity but the sensitivity of measurement tools may also be limiting. Measuring action potential, calcium flux or contraction individually misses critical information that is captured when interrogating the complete excitation-contraction coupling cascade simultaneously. Here, we develop an hypothesis-based statistical algorithm that identifies mechanisms of action. We design and build a high-speed optical system to measure action potential, cytosolic calcium and contraction simultaneously using fluorescent sensors. These measurements are automatically processed, quantified and then assessed by the algorithm. Multiplexing these three critical physical features of hiPSC-CMs allows identification of all major drug classes affecting contractility with detection sensitivities higher than individual measurement of action potential, cytosolic calcium or contraction. Cardiomyocytes obtained from human induced pluripotent stem cells are increasingly used for drug testing, but they are not always predictive of the heart contractile responses. Here the authors develop a method to measure cytosolic calcium, action potentials and contraction simultaneously, to achieve higher sensitivity for drug screenings.

[1]  Godfrey L. Smith,et al.  A Versatile Open Software Tool to Quantify Cardiomyocyte and Cardiac Muscle Contraction In Vitro and In Vivo , 2018 .

[2]  Baolin Zhang,et al.  Doxorubicin induces cardiotoxicity through upregulation of death receptors mediated apoptosis in cardiomyocytes , 2017, Scientific Reports.

[3]  V. J. Planelles-Herrero,et al.  Mechanistic and structural basis for activation of cardiac myosin force production by omecamtiv mecarbil , 2017, Nature Communications.

[4]  Flavio H. Fenton,et al.  Robust framework for quantitative analysis of optical mapping signals without filtering , 2015, 2015 Computing in Cardiology Conference (CinC).

[5]  E. Krause,et al.  (-)-Adrenaline elicits positive inotropic, lusitropic, and biochemical effects through β2-adrenoceptors in human atrial myocardium from nonfailing and failing hearts, consistent with Gs coupling but not with Gi coupling , 2007, Naunyn-Schmiedeberg's Archives of Pharmacology.

[6]  Godfrey L. Smith,et al.  The Use of Ratiometric Fluorescence Measurements of the Voltage Sensitive Dye Di-4-ANEPPS to Examine Action Potential Characteristics and Drug Effects on Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes , 2016, Toxicological sciences : an official journal of the Society of Toxicology.

[7]  A. Pointon,et al.  Preservation of cardiomyocytes from the adult heart. , 2013, Journal of molecular and cellular cardiology.

[8]  T. Akera,et al.  Comparison of cardiac actions of doxorubicin, pirarubicin and aclarubicin in isolated guinea-pig heart. , 1993, European journal of pharmacology.

[9]  James Winter,et al.  The mechanical uncoupler blebbistatin is associated with significant electrophysiological effects in the isolated rabbit heart , 2013, Experimental physiology.

[10]  K. Jakobs,et al.  Activation of calcium currents in cardiac myocytes by empty beta-adrenoceptors. , 1993, Circulation.

[11]  Elizabeth M Cherry,et al.  Suppression of alternans and conduction blocks despite steep APD restitution: electrotonic, memory, and conduction velocity restitution effects. , 2004, American journal of physiology. Heart and circulatory physiology.

[12]  A. Pointon,et al.  From the Cover: High-Throughput Imaging of Cardiac Microtissues for the Assessment of Cardiac Contraction during Drug Discovery , 2017, Toxicological sciences : an official journal of the Society of Toxicology.

[13]  Mike Clements,et al.  Bridging Functional and Structural Cardiotoxicity Assays Using Human Embryonic Stem Cell-Derived Cardiomyocytes for a More Comprehensive Risk Assessment. , 2015, Toxicological sciences : an official journal of the Society of Toxicology.

[14]  R. F. Gilmour,et al.  Electromechanical vortex filaments during cardiac fibrillation , 2018, Nature.

[15]  T. Colatsky,et al.  The Comprehensive in Vitro Proarrhythmia Assay (CiPA) initiative - Update on progress. , 2016, Journal of pharmacological and toxicological methods.

[16]  P. Schwartz,et al.  The Pharmacokinetics of Isoproterenol in Critically Ill Pediatric Patients , 1993, Journal of clinical pharmacology.

[17]  Thomas Weiser,et al.  The Electrophysiological Effects of Cardiac Glycosides in Human iPSC-derived Cardiomyocytes and in Guinea Pig Isolated Hearts , 2011, Cellular Physiology and Biochemistry.

[18]  Luca Sala,et al.  Electrophysiological Analysis of human Pluripotent Stem Cell-derived Cardiomyocytes (hPSC-CMs) Using Multi-electrode Arrays (MEAs) , 2017, Journal of visualized experiments : JoVE.

[19]  W. Knight,et al.  Therapeutic potential of PDE modulation in treating heart disease. , 2013, Future medicinal chemistry.

[20]  Christine L. Mummery,et al.  Concise Review: Measuring Physiological Responses of Human Pluripotent Stem Cell Derived Cardiomyocytes to Drugs and Disease , 2016, Stem cells.

[21]  M. Gotsman,et al.  Endogenous ouabain-like compound increases heart muscle contractility , 1984, Nature.

[22]  A. Camm,et al.  Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development. , 2003, Cardiovascular research.

[23]  H. Fuerstenwerth On the Differences Between Ouabain and Digitalis Glycosides , 2014, American journal of therapeutics.

[24]  K. Giacomini,et al.  Decreased Binding of Verapamil to Plasma Proteins in Patients with Liver Disease , 1984, Journal of cardiovascular pharmacology.

[25]  Y. Honda,et al.  Usefulness of cardiotoxicity assessment using calcium transient in human induced pluripotent stem cell-derived cardiomyocytes. , 2017, The Journal of toxicological sciences.

[27]  J. Cleland,et al.  The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial , 2011, The Lancet.

[28]  Qixing Huang,et al.  Use of RNAi technology to develop a PRSV-resistant transgenic papaya , 2017, Scientific Reports.

[29]  Milena Bellin,et al.  Recessive cardiac phenotypes in induced pluripotent stem cell models of Jervell and Lange-Nielsen syndrome: Disease mechanisms and pharmacological rescue , 2014, Proceedings of the National Academy of Sciences.

[30]  Bruce R. Conklin,et al.  A Non-invasive Platform for Functional Characterization of Stem-Cell-Derived Cardiomyocytes with Applications in Cardiotoxicity Testing , 2015, Stem cell reports.

[31]  Gordon Keller,et al.  Mechanical Stress Promotes Maturation of Human Myocardium From Pluripotent Stem Cell‐Derived Progenitors , 2015, Stem cells.

[32]  G Duker,et al.  Electrophysiological and inotropic effects of H 234/09 (almokalant) in vitro: a comparison with two other novel IK blocking drugs, UK-68,798 (dofetilide) and E-4031. , 1993, Cardiovascular research.

[33]  Robert Passier,et al.  Prediction of drug-induced cardiotoxicity using human embryonic stem cell-derived cardiomyocytes. , 2010, Stem cell research.

[34]  Amy Pointon,et al.  Assessment of cardiomyocyte contraction in human-induced pluripotent stem cell-derived cardiomyocytes. , 2015, Toxicological sciences : an official journal of the Society of Toxicology.

[35]  Hauke Furstenwerth Ouabain – the insulin of the heart , 2010 .

[36]  Christine L. Mummery,et al.  Contractile Defect Caused by Mutation in MYBPC3 Revealed under Conditions Optimized for Human PSC-Cardiomyocyte Function , 2015, Cell reports.

[37]  R. K. Justice,et al.  Ratiometry of transmembrane voltage-sensitive fluorescent dye emission in hearts. , 2000, American journal of physiology. Heart and circulatory physiology.

[38]  D. Bers Cardiac excitation–contraction coupling , 2002, Nature.

[39]  David G Strauss,et al.  Comprehensive Translational Assessment of Human-Induced Pluripotent Stem Cell Derived Cardiomyocytes for Evaluating Drug-Induced Arrhythmias , 2017, Toxicological sciences : an official journal of the Society of Toxicology.

[40]  T. Bányász,et al.  Frequency-dependent effects of omecamtiv mecarbil on cell shortening of isolated canine ventricular cardiomyocytes , 2017, Naunyn-Schmiedeberg's Archives of Pharmacology.

[41]  Martin J. Lohse,et al.  What Is the Role of &bgr;-Adrenergic Signaling in Heart Failure? , 2003, Circulation research.

[42]  Praveen Shukla,et al.  High-throughput screening of tyrosine kinase inhibitor cardiotoxicity with human induced pluripotent stem cells , 2017, Science Translational Medicine.

[43]  M. Böhm,et al.  Contribution of cAMP-phosphodiesterase inhibition and sensitization of the contractile proteins for calcium to the inotropic effect of pimobendan in the failing human myocardium. , 1991, Circulation research.

[44]  Amy D. Hanna,et al.  Adverse Effects of Doxorubicin and Its Metabolic Product on Cardiac RyR2 and SERCA2A , 2014, Molecular Pharmacology.

[45]  Adriaan P IJzerman,et al.  A new hERG allosteric modulator rescues genetic and drug‐induced long‐QT syndrome phenotypes in cardiomyocytes from isogenic pairs of patient induced pluripotent stem cells , 2016, EMBO molecular medicine.

[46]  Christine L. Mummery,et al.  Three-dimensional cardiac microtissues composed of cardiomyocytes and endothelial cells co-differentiated from human pluripotent stem cells , 2017, Development.

[47]  Jackie Schiller,et al.  Calcium Handling in Human Induced Pluripotent Stem Cell Derived Cardiomyocytes , 2011, PloS one.

[48]  Godfrey L. Smith,et al.  MUSCLEMOTION , 2017, Circulation research.

[49]  Torsten Christ,et al.  Blinded Contractility Analysis in hiPSC-Cardiomyocytes in Engineered Heart Tissue Format: Comparison With Human Atrial Trabeculae , 2017, Toxicological sciences : an official journal of the Society of Toxicology.

[50]  C. Cohen,et al.  A Dihydropyridine (Bay k 8644) That Enhances Calcium Currents in Guinea Pig and Calf Myocardial Cells: A New Type of Positive Inotropic Agent , 1985, Circulation research.

[51]  K. Jakobs,et al.  Activation of Calcium Currents in Cardiac Myocytes by Empt j‐Adrenoceptors , 1993 .

[52]  U. Ravens,et al.  Characterization of the effects of the new inotropic agent BDF 9148 in isolated papillary muscles and myocytes of the guinea‐pig heart , 1991, British journal of pharmacology.

[53]  G. Pazour,et al.  Ror2 signaling regulates Golgi structure and transport through IFT20 for tumor invasiveness , 2017, Scientific Reports.

[54]  Herbert Schulz,et al.  Human Engineered Heart Tissue: Analysis of Contractile Force , 2016, Stem cell reports.

[55]  G. Ellrodt,et al.  Verapamil: A Review of its Pharmacological Properties and Therapeutic Use , 1978, Drugs.

[56]  Liang Guo,et al.  Estimating the risk of drug-induced proarrhythmia using human induced pluripotent stem cell-derived cardiomyocytes. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.

[57]  H. Reichenspurner,et al.  Human iPSC-derived cardiomyocytes cultured in 3D engineered heart tissue show physiological upstroke velocity and sodium current density , 2017, Scientific Reports.